Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Labtec is a leading German-based CDMO specializing in innovative drug delivery systems—primarily transdermal patches and fast-dissolving oral films—using proprietary platforms such as RapidFilm®. The company has supported multiple successful clinical programs through to regulatory approval in both Europe and the US via strategic partnerships with pharma companies. Notably, its technologies have enabled approvals of ondansetron oral dispersible films in both regions. As a service provider/CDMO rather than an innovator with its own pipeline assets, clinical results pertain to partnered or licensed products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Labtec.